Multiple Manufacturers

DEFEROXAMINE MESYLATE

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Multiple Manufacturers

Deferoxamine Mesylate HCPCS:

J0895

HCPCS Code Descriptor:

Injection, deferoxamine mesylate, 500 mg

Category:

J Code

Deferoxamine Mesylate NDCs:

52609-4504-06, 60505-6237-06, 00078-0467-91, 00409-2337-25, 60505-6236-06, 60505-6238-06, 52609-4505-06, 00078-0467-61, 63323-0599-30, 60505-6237-00, 60505-6236-00, 47781-0624-07, 63323-0597-10

Primary Type:

Unclassified

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Injection

Deferoxamine Mesylate CPT Codes:

Potential CPT administration codes for Deferoxamine Mesylate can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

52609-4504-06, 60505-6237-06, 00078-0467-91, 00409-2337-25, 60505-6236-06, 60505-6238-06, 52609-4505-06, 00078-0467-61

About Deferoxamine Mesylate:

DEFEROXAMINE MESYLATE is a medication manufactured by multiple manufacturers and aligned to the J Code: J0895. DEFEROXAMINE MESYLATE is administered via the injection route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J0895 Added Date:

January 1, 1992

J0895 Effective Date:

January 1, 2001

J0895 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Deferoxamine Mesylate billing and coding information.
Our team did not identify a source for Deferoxamine Mesylate patient assistance information. Please reach out to our team if you feel that this is a mistake.
DEFEROXAMINE MESYLATE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for DEFEROXAMINE MESYLATE. Please check back in a few weeks.